Table of Content

1 Market Overview of Cell and Gene Therapy CDMO
1.1 Cell and Gene Therapy CDMO Market Overview
1.1.1 Cell and Gene Therapy CDMO Product Scope
1.1.2 Cell and Gene Therapy CDMO Market Status and Outlook
1.2 Global Cell and Gene Therapy CDMO Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Cell and Gene Therapy CDMO Market Size by Region (2018-2033)
1.4 Global Cell and Gene Therapy CDMO Historic Market Size by Region (2018-2023)
1.5 Global Cell and Gene Therapy CDMO Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Cell and Gene Therapy CDMO Market Size (2018-2033)
1.6.1 North America Cell and Gene Therapy CDMO Market Size (2018-2033)
1.6.2 Europe Cell and Gene Therapy CDMO Market Size (2018-2033)
1.6.3 Asia-Pacific Cell and Gene Therapy CDMO Market Size (2018-2033)
1.6.4 Latin America Cell and Gene Therapy CDMO Market Size (2018-2033)
1.6.5 Middle East & Africa Cell and Gene Therapy CDMO Market Size (2018-2033)
2 Cell and Gene Therapy CDMO Market by Type
2.1 Introduction
2.1.1 Clinical Trial Material CDMOs
2.1.2 Development and Manufacturing CDMOs
2.1.3 Other
2.2 Global Cell and Gene Therapy CDMO Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Cell and Gene Therapy CDMO Historic Market Size by Type (2018-2023)
2.2.2 Global Cell and Gene Therapy CDMO Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Cell and Gene Therapy CDMO Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Cell and Gene Therapy CDMO Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Cell and Gene Therapy CDMO Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Cell and Gene Therapy CDMO Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Cell and Gene Therapy CDMO Revenue Breakdown by Type (2018-2033)
3 Cell and Gene Therapy CDMO Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical Company
3.1.2 Biotechnology Company
3.1.3 Other
3.2 Global Cell and Gene Therapy CDMO Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Cell and Gene Therapy CDMO Historic Market Size by Application (2018-2023)
3.2.2 Global Cell and Gene Therapy CDMO Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Cell and Gene Therapy CDMO Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Cell and Gene Therapy CDMO Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Cell and Gene Therapy CDMO Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Cell and Gene Therapy CDMO Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Cell and Gene Therapy CDMO Revenue Breakdown by Application (2018-2033)
4 Cell and Gene Therapy CDMO Competition Analysis by Players
4.1 Global Cell and Gene Therapy CDMO Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cell and Gene Therapy CDMO as of 2022)
4.3 Date of Key Players Enter into Cell and Gene Therapy CDMO Market
4.4 Global Top Players Cell and Gene Therapy CDMO Headquarters and Area Served
4.5 Key Players Cell and Gene Therapy CDMO Product Solution and Service
4.6 Competitive Status
4.6.1 Cell and Gene Therapy CDMO Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Lonza
5.1.1 Lonza Profile
5.1.2 Lonza Main Business
5.1.3 Lonza Cell and Gene Therapy CDMO Products, Services and Solutions
5.1.4 Lonza Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.1.5 Lonza Recent Developments
5.2 Charles River Laboratories
5.2.1 Charles River Laboratories Profile
5.2.2 Charles River Laboratories Main Business
5.2.3 Charles River Laboratories Cell and Gene Therapy CDMO Products, Services and Solutions
5.2.4 Charles River Laboratories Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.2.5 Charles River Laboratories Recent Developments
5.3 Cytiva
5.3.1 Cytiva Profile
5.3.2 Cytiva Main Business
5.3.3 Cytiva Cell and Gene Therapy CDMO Products, Services and Solutions
5.3.4 Cytiva Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.3.5 Catalent Biologics Recent Developments
5.4 Catalent Biologics
5.4.1 Catalent Biologics Profile
5.4.2 Catalent Biologics Main Business
5.4.3 Catalent Biologics Cell and Gene Therapy CDMO Products, Services and Solutions
5.4.4 Catalent Biologics Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.4.5 Catalent Biologics Recent Developments
5.5 FUJIFILM Diosynth Biotechnologies
5.5.1 FUJIFILM Diosynth Biotechnologies Profile
5.5.2 FUJIFILM Diosynth Biotechnologies Main Business
5.5.3 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Products, Services and Solutions
5.5.4 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.5.5 FUJIFILM Diosynth Biotechnologies Recent Developments
5.6 BioCentriq
5.6.1 BioCentriq Profile
5.6.2 BioCentriq Main Business
5.6.3 BioCentriq Cell and Gene Therapy CDMO Products, Services and Solutions
5.6.4 BioCentriq Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.6.5 BioCentriq Recent Developments
5.7 RoslinCT
5.7.1 RoslinCT Profile
5.7.2 RoslinCT Main Business
5.7.3 RoslinCT Cell and Gene Therapy CDMO Products, Services and Solutions
5.7.4 RoslinCT Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.7.5 RoslinCT Recent Developments
5.8 Thermo Scientific
5.8.1 Thermo Scientific Profile
5.8.2 Thermo Scientific Main Business
5.8.3 Thermo Scientific Cell and Gene Therapy CDMO Products, Services and Solutions
5.8.4 Thermo Scientific Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.8.5 Thermo Scientific Recent Developments
5.9 Mesoblast
5.9.1 Mesoblast Profile
5.9.2 Mesoblast Main Business
5.9.3 Mesoblast Cell and Gene Therapy CDMO Products, Services and Solutions
5.9.4 Mesoblast Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.9.5 Mesoblast Recent Developments
5.10 Cellularity
5.10.1 Cellularity Profile
5.10.2 Cellularity Main Business
5.10.3 Cellularity Cell and Gene Therapy CDMO Products, Services and Solutions
5.10.4 Cellularity Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.10.5 Cellularity Recent Developments
5.11 Bluebird Bio
5.11.1 Bluebird Bio Profile
5.11.2 Bluebird Bio Main Business
5.11.3 Bluebird Bio Cell and Gene Therapy CDMO Products, Services and Solutions
5.11.4 Bluebird Bio Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.11.5 Bluebird Bio Recent Developments
5.12 Editas Medicine
5.12.1 Editas Medicine Profile
5.12.2 Editas Medicine Main Business
5.12.3 Editas Medicine Cell and Gene Therapy CDMO Products, Services and Solutions
5.12.4 Editas Medicine Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.12.5 Editas Medicine Recent Developments
5.13 Andelyn Biosciences
5.13.1 Andelyn Biosciences Profile
5.13.2 Andelyn Biosciences Main Business
5.13.3 Andelyn Biosciences Cell and Gene Therapy CDMO Products, Services and Solutions
5.13.4 Andelyn Biosciences Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.13.5 Andelyn Biosciences Recent Developments
5.14 Wuxi Advanced Therapies
5.14.1 Wuxi Advanced Therapies Profile
5.14.2 Wuxi Advanced Therapies Main Business
5.14.3 Wuxi Advanced Therapies Cell and Gene Therapy CDMO Products, Services and Solutions
5.14.4 Wuxi Advanced Therapies Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.14.5 Wuxi Advanced Therapies Recent Developments
5.15 AGC Biologics
5.15.1 AGC Biologics Profile
5.15.2 AGC Biologics Main Business
5.15.3 AGC Biologics Cell and Gene Therapy CDMO Products, Services and Solutions
5.15.4 AGC Biologics Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.15.5 AGC Biologics Recent Developments
5.16 Pfizer CentreOne
5.16.1 Pfizer CentreOne Profile
5.16.2 Pfizer CentreOne Main Business
5.16.3 Pfizer CentreOne Cell and Gene Therapy CDMO Products, Services and Solutions
5.16.4 Pfizer CentreOne Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.16.5 Pfizer CentreOne Recent Developments
5.17 Almac Group
5.17.1 Almac Group Profile
5.17.2 Almac Group Main Business
5.17.3 Almac Group Cell and Gene Therapy CDMO Products, Services and Solutions
5.17.4 Almac Group Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.17.5 Almac Group Recent Developments
5.18 PCI Pharma Services
5.18.1 PCI Pharma Services Profile
5.18.2 PCI Pharma Services Main Business
5.18.3 PCI Pharma Services Cell and Gene Therapy CDMO Products, Services and Solutions
5.18.4 PCI Pharma Services Cell and Gene Therapy CDMO Revenue (US$ Million) & (2018-2023)
5.18.5 PCI Pharma Services Recent Developments
6 North America
6.1 North America Cell and Gene Therapy CDMO Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Cell and Gene Therapy CDMO Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy CDMO Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cell and Gene Therapy CDMO Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy CDMO Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cell and Gene Therapy CDMO Market Dynamics
11.1 Cell and Gene Therapy CDMO Industry Trends
11.2 Cell and Gene Therapy CDMO Market Drivers
11.3 Cell and Gene Therapy CDMO Market Challenges
11.4 Cell and Gene Therapy CDMO Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Cell and Gene Therapy CDMO Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Cell and Gene Therapy CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Cell and Gene Therapy CDMO Market Size Share by Region (2018-2023)
Table 4. Global Cell and Gene Therapy CDMO Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Cell and Gene Therapy CDMO Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Cell and Gene Therapy CDMO Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Cell and Gene Therapy CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Cell and Gene Therapy CDMO Revenue Market Share by Type (2018-2023)
Table 9. Global Cell and Gene Therapy CDMO Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Cell and Gene Therapy CDMO Revenue Market Share by Type (2024-2033)
Table 11. North America Cell and Gene Therapy CDMO Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Cell and Gene Therapy CDMO Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Cell and Gene Therapy CDMO Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Cell and Gene Therapy CDMO Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Cell and Gene Therapy CDMO Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Cell and Gene Therapy CDMO Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Cell and Gene Therapy CDMO Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Cell and Gene Therapy CDMO Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Cell and Gene Therapy CDMO Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Cell and Gene Therapy CDMO Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Cell and Gene Therapy CDMO Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Cell and Gene Therapy CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Cell and Gene Therapy CDMO Revenue Market Share by Application (2018-2023)
Table 24. Global Cell and Gene Therapy CDMO Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Cell and Gene Therapy CDMO Revenue Market Share by Application (2024-2033)
Table 26. North America Cell and Gene Therapy CDMO Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Cell and Gene Therapy CDMO Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Cell and Gene Therapy CDMO Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Cell and Gene Therapy CDMO Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Cell and Gene Therapy CDMO Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Cell and Gene Therapy CDMO Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Cell and Gene Therapy CDMO Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Cell and Gene Therapy CDMO Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Cell and Gene Therapy CDMO Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Cell and Gene Therapy CDMO Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Cell and Gene Therapy CDMO Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Cell and Gene Therapy CDMO Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cell and Gene Therapy CDMO as of 2022)
Table 39. Date of Key Players Enter into Cell and Gene Therapy CDMO Market
Table 40. Global Cell and Gene Therapy CDMO Key Players Headquarters and Area Served
Table 41. Cell and Gene Therapy CDMO Product Solution and Service
Table 42. Global Cell and Gene Therapy CDMO Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Lonza Basic Information List
Table 45. Lonza Description and Business Overview
Table 46. Lonza Cell and Gene Therapy CDMO Products, Services and Solutions
Table 47. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of Lonza (2018-2023)
Table 48. Lonza Recent Developments
Table 49. Charles River Laboratories Basic Information List
Table 50. Charles River Laboratories Description and Business Overview
Table 51. Charles River Laboratories Cell and Gene Therapy CDMO Products, Services and Solutions
Table 52. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of Charles River Laboratories (2018-2023)
Table 53. Charles River Laboratories Recent Developments
Table 54. Cytiva Basic Information List
Table 55. Cytiva Description and Business Overview
Table 56. Cytiva Cell and Gene Therapy CDMO Products, Services and Solutions
Table 57. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of Cytiva (2018-2023)
Table 58. Cytiva Recent Developments
Table 59. Catalent Biologics Basic Information List
Table 60. Catalent Biologics Description and Business Overview
Table 61. Catalent Biologics Cell and Gene Therapy CDMO Products, Services and Solutions
Table 62. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of Catalent Biologics (2018-2023)
Table 63. Catalent Biologics Recent Developments
Table 64. FUJIFILM Diosynth Biotechnologies Basic Information List
Table 65. FUJIFILM Diosynth Biotechnologies Description and Business Overview
Table 66. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Products, Services and Solutions
Table 67. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of FUJIFILM Diosynth Biotechnologies (2018-2023)
Table 68. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 69. BioCentriq Basic Information List
Table 70. BioCentriq Description and Business Overview
Table 71. BioCentriq Cell and Gene Therapy CDMO Products, Services and Solutions
Table 72. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of BioCentriq (2018-2023)
Table 73. BioCentriq Recent Developments
Table 74. RoslinCT Basic Information List
Table 75. RoslinCT Description and Business Overview
Table 76. RoslinCT Cell and Gene Therapy CDMO Products, Services and Solutions
Table 77. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of RoslinCT (2018-2023)
Table 78. RoslinCT Recent Developments
Table 79. Thermo Scientific Basic Information List
Table 80. Thermo Scientific Description and Business Overview
Table 81. Thermo Scientific Cell and Gene Therapy CDMO Products, Services and Solutions
Table 82. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of Thermo Scientific (2018-2023)
Table 83. Thermo Scientific Recent Developments
Table 84. Mesoblast Basic Information List
Table 85. Mesoblast Description and Business Overview
Table 86. Mesoblast Cell and Gene Therapy CDMO Products, Services and Solutions
Table 87. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of Mesoblast (2018-2023)
Table 88. Mesoblast Recent Developments
Table 89. Cellularity Basic Information List
Table 90. Cellularity Description and Business Overview
Table 91. Cellularity Cell and Gene Therapy CDMO Products, Services and Solutions
Table 92. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of Cellularity (2018-2023)
Table 93. Cellularity Recent Developments
Table 94. Bluebird Bio Basic Information List
Table 95. Bluebird Bio Description and Business Overview
Table 96. Bluebird Bio Cell and Gene Therapy CDMO Products, Services and Solutions
Table 97. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of Bluebird Bio (2018-2023)
Table 98. Bluebird Bio Recent Developments
Table 99. Editas Medicine Basic Information List
Table 100. Editas Medicine Description and Business Overview
Table 101. Editas Medicine Cell and Gene Therapy CDMO Products, Services and Solutions
Table 102. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of Editas Medicine (2018-2023)
Table 103. Editas Medicine Recent Developments
Table 104. Andelyn Biosciences Basic Information List
Table 105. Andelyn Biosciences Description and Business Overview
Table 106. Andelyn Biosciences Cell and Gene Therapy CDMO Products, Services and Solutions
Table 107. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of Andelyn Biosciences (2018-2023)
Table 108. Andelyn Biosciences Recent Developments
Table 109. Wuxi Advanced Therapies Basic Information List
Table 110. Wuxi Advanced Therapies Description and Business Overview
Table 111. Wuxi Advanced Therapies Cell and Gene Therapy CDMO Products, Services and Solutions
Table 112. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of Wuxi Advanced Therapies (2018-2023)
Table 113. Wuxi Advanced Therapies Recent Developments
Table 114. AGC Biologics Basic Information List
Table 115. AGC Biologics Description and Business Overview
Table 116. AGC Biologics Cell and Gene Therapy CDMO Products, Services and Solutions
Table 117. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of AGC Biologics (2018-2023)
Table 118. AGC Biologics Recent Developments
Table 119. Pfizer CentreOne Basic Information List
Table 120. Pfizer CentreOne Description and Business Overview
Table 121. Pfizer CentreOne Cell and Gene Therapy CDMO Products, Services and Solutions
Table 122. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of Pfizer CentreOne (2018-2023)
Table 123. Pfizer CentreOne Recent Developments
Table 124. Almac Group Basic Information List
Table 125. Almac Group Description and Business Overview
Table 126. Almac Group Cell and Gene Therapy CDMO Products, Services and Solutions
Table 127. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of Almac Group (2018-2023)
Table 128. Almac Group Recent Developments
Table 129. PCI Pharma Services Basic Information List
Table 130. PCI Pharma Services Description and Business Overview
Table 131. PCI Pharma Services Cell and Gene Therapy CDMO Products, Services and Solutions
Table 132. Revenue (US$ Million) in Cell and Gene Therapy CDMO Business of PCI Pharma Services (2018-2023)
Table 133. PCI Pharma Services Recent Developments
Table 134. North America Cell and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 135. North America Cell and Gene Therapy CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 136. Europe Cell and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 137. Europe Cell and Gene Therapy CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 138. Asia-Pacific Cell and Gene Therapy CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 139. Asia-Pacific Cell and Gene Therapy CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 140. Asia-Pacific Cell and Gene Therapy CDMO Market Size by Region (2024-2033) & (US$ Million)
Table 141. Asia-Pacific Cell and Gene Therapy CDMO Market Share by Region (2018-2023)
Table 142. Asia-Pacific Cell and Gene Therapy CDMO Market Share by Region (2024-2033)
Table 143. Latin America Cell and Gene Therapy CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 144. Latin America Cell and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 145. Latin America Cell and Gene Therapy CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 146. Middle East & Africa Cell and Gene Therapy CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 147. Middle East & Africa Cell and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 148. Middle East & Africa Cell and Gene Therapy CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 149. Cell and Gene Therapy CDMO Market Trends
Table 150. Cell and Gene Therapy CDMO Market Drivers
Table 151. Cell and Gene Therapy CDMO Market Challenges
Table 152. Cell and Gene Therapy CDMO Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell and Gene Therapy CDMO Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Cell and Gene Therapy CDMO Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Cell and Gene Therapy CDMO Market Share by Regions: 2022 VS 2033
Figure 4. Global Cell and Gene Therapy CDMO Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Cell and Gene Therapy CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Cell and Gene Therapy CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Cell and Gene Therapy CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Cell and Gene Therapy CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Cell and Gene Therapy CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Clinical Trial Material CDMOs
Figure 11. Global Clinical Trial Material CDMOs Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Development and Manufacturing CDMOs
Figure 13. Global Development and Manufacturing CDMOs Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Other
Figure 15. Global Other Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Global Cell and Gene Therapy CDMO Market Size Share by Type: 2022 & 2033
Figure 17. North America Cell and Gene Therapy CDMO Revenue Market Share by Type (2018-2033)
Figure 18. Europe Cell and Gene Therapy CDMO Revenue Market Share by Type (2018-2033)
Figure 19. Asia-Pacific Cell and Gene Therapy CDMO Revenue Market Share by Type (2018-2033)
Figure 20. Latin America Cell and Gene Therapy CDMO Revenue Market Share by Type (2018-2033)
Figure 21. Middle East and Africa Cell and Gene Therapy CDMO Revenue Market Share by Type (2018-2033)
Figure 22. Pharmaceutical Company Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Biotechnology Company Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Other Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Global Cell and Gene Therapy CDMO Market Size Share by Application: 2022 & 2033
Figure 26. North America Cell and Gene Therapy CDMO Revenue Market Share by Application (2018-2033)
Figure 27. Europe Cell and Gene Therapy CDMO Revenue Market Share by Application (2018-2033)
Figure 28. Asia-Pacific Cell and Gene Therapy CDMO Revenue Market Share by Application (2018-2033)
Figure 29. Latin America Cell and Gene Therapy CDMO Revenue Market Share by Application (2018-2033)
Figure 30. Middle East and Africa Cell and Gene Therapy CDMO Revenue Market Share by Application (2018-2033)
Figure 31. Cell and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 32. Global Top 5 and Top 10 Players Cell and Gene Therapy CDMO Market Share in 2022
Figure 33. North America Cell and Gene Therapy CDMO Market Share by Country (2018-2033)
Figure 34. United States Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 35. Canada Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 36. Germany Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 37. France Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 38. U.K. Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 39. Italy Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 40. Russia Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 41. Nordic Countries Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 42. Asia-Pacific Cell and Gene Therapy CDMO Market Share by Region (2018-2033)
Figure 43. China Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 44. Japan Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 45. South Korea Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 47. India Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 48. Australia Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 49. Latin America Cell and Gene Therapy CDMO Market Share by Country (2018-2033)
Figure 50. Mexico Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 51. Brazil Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 52. Middle East & Africa Cell and Gene Therapy CDMO Market Share by Country (2018-2033)
Figure 53. Turkey Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 55. UAE Cell and Gene Therapy CDMO Market Size (2018-2033) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report